Maria Trinh
Medical · Pasadena, CANPI 1023369667
Payments from drug & device makers
Across 640 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Incyte Corporation$1K
- AbbVie$1K
- Johnson & Johnson$844
- E.r. Squibb & Sons, L.L.C.$833
- plus $7K from 27 others
What the payments were for
- Food & beverage$13,60795%
- Education$6825%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 58 | $2,083 |
| Regeneron Healthcare Solutions, Inc. | 43 | $1,422 |
| Incyte Corporation | 80 | $1,273 |
| AbbVie | 43 | $1,047 |
| Johnson & Johnson | 31 | $844 |
| E.r. Squibb & Sons, L.L.C. | 51 | $833 |
| UCB, Inc. | 30 | $817 |
| LEO Pharma Inc. | 47 | $781 |
| Pfizer | 41 | $726 |
| Sun Pharmaceutical Industries Inc. | 37 | $706 |
| Amgen | 34 | $706 |
| Arcutis Biotherapeutics, Inc. | 38 | $670 |
| Lilly USA, LLC | 18 | $460 |
| Dermavant Sciences, Inc. | 16 | $339 |
| Galderma Laboratories, L.p. | 15 | $282 |
| Novartis | 12 | $276 |
| Almirall LLC | 8 | $197 |
| Strata Skin Sciences, Inc. | 2 | $179 |
| Mayne Pharma Commercial LLC | 12 | $130 |
| ANI Pharmaceuticals, Inc. | 5 | $105 |
| Journey Medical Corporation | 3 | $65 |
| Organogenesis Inc. | 3 | $60 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $41 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Vertex | 1 | $32 |
| Botanix SB Inc | 1 | $30 |
| EPI Health, LLC | 1 | $28 |
| Phadia US Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Sandoz | 1 | $22 |
| LNHC, Inc | 1 | $18 |
| Organon | 1 | $14 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTRAC$158
How this compares
$14,289 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 21 | $280,427 |
| OtezlaApremilast | 46 | $220,730 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $132,697 |
| Dupixent PenDupilumab | 34 | $125,923 |
| OpzeluraRuxolitinib Phosphate | 47 | $89,735 |
| ZoryveRoflumilast | 42 | $39,658 |
| Pimecrolimus | 25 | $5,739 |
| Tacrolimus | 35 | $4,104 |
| Ketoconazole | 227 | $3,138 |
| Fluorouracil | 37 | $2,364 |
| Clobetasol Propionate | 64 | $2,163 |
| Betamethasone Dipropionate | 48 | $1,893 |
| Clindamycin Phosphate | 74 | $1,675 |
| Fluocinolone Acetonide | 32 | $1,590 |
| Fluocinonide | 58 | $1,539 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $844 | $280,42721 claims |
| AmgenOtezla | $706 | $220,73046 claims |
| Incyte CorporationOpzelura | $1,273 | $89,73547 claims |
| Arcutis Biotherapeutics, Inc.Zoryve | $670 | $39,65842 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in Pasadena
- Jamie CordobaPasadena$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.